4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine

C103H77BrCl2N26O2 — CID 159478924

IUPAC4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine
SMILESCc1nc2ccc(-c3ncc(N)nc3-c3ccccc3)cc2[nH]1.Nc1cnc(-c2cc(Cl)c3nc[nH]c3c2)c(-c2ccccc2)n1.Nc1cnc(-c2ccc(O)c(Cl)c2)c(-c2ccco2)n1.Nc1cnc(-c2ccc3[nH]ccc3c2)c(-c2ccccc2)n1.Nc1cnc(-c2ccc3nc[nH]c3c2)c(-c2ccccc2)n1.Nc1nc(-c2ccccc2)c(-c2ccc3ncccc3c2)nc1Br
InChIInChI=1S/C19H13BrN4.C18H15N5.C18H14N4.C17H12ClN5.C17H13N5.C14H10ClN3O2/c20-18-19(21)24-16(12-5-2-1-3-6-12)17(23-18)14-8-9-15-13(11-14)7-4-10-22-15;1-11-21-14-8-7-13(9-15(14)22-11)17-18(23-16(19)10-20-17)12-5-3-2-4-6-12;19-16-11-21-17(18(22-16)12-4-2-1-3-5-12)14-6-7-15-13(10-14)8-9-20-15;18-12-6-11(7-13-17(12)22-9-21-13)15-16(23-14(19)8-20-15)10-4-2-1-3-5-10;18-15-9-19-16(17(22-15)11-4-2-1-3-5-11)12-6-7-13-14(8-12)21-10-20-13;15-9-6-8(3-4-10(9)19)13-14(11-2-1-5-20-11)18-12(16)7-17-13/h1-11H,(H2,21,24);2-10H,1H3,(H2,19,23)(H,21,22);1-11,20H,(H2,19,22);1-9H,(H2,19,23)(H,21,22);1-10H,(H2,18,22)(H,20,21);1-7,19H,(H2,16,18)
InChIKeyLWTBDLSAOYVQAG-UHFFFAOYSA-N
MW1861.74 g/mol
LogP22.69
Rot. Bonds12

About 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine

4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine (PubChem CID 159478924) has the molecular formula C103H77BrCl2N26O2 and a molecular weight of 1861.74 g/mol. Its IUPAC name is 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine.

Molecular Properties

Compound Name4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine
PubChem CID159478924
Molecular FormulaC103H77BrCl2N26O2
Molecular Weight1861.74 g/mol
Exact Mass1858.53
IUPAC Name4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine
SMILESCc1nc2ccc(-c3ncc(N)nc3-c3ccccc3)cc2[nH]1.Nc1cnc(-c2cc(Cl)c3nc[nH]c3c2)c(-c2ccccc2)n1.Nc1cnc(-c2ccc(O)c(Cl)c2)c(-c2ccco2)n1.Nc1cnc(-c2ccc3[nH]ccc3c2)c(-c2ccccc2)n1.Nc1cnc(-c2ccc3nc[nH]c3c2)c(-c2ccccc2)n1.Nc1nc(-c2ccccc2)c(-c2ccc3ncccc3c2)nc1Br
InChIInChI=1S/C19H13BrN4.C18H15N5.C18H14N4.C17H12ClN5.C17H13N5.C14H10ClN3O2/c20-18-19(21)24-16(12-5-2-1-3-6-12)17(23-18)14-8-9-15-13(11-14)7-4-10-22-15;1-11-21-14-8-7-13(9-15(14)22-11)17-18(23-16(19)10-20-17)12-5-3-2-4-6-12;19-16-11-21-17(18(22-16)12-4-2-1-3-5-12)14-6-7-15-13(10-14)8-9-20-15;18-12-6-11(7-13-17(12)22-9-21-13)15-16(23-14(19)8-20-15)10-4-2-1-3-5-10;18-15-9-19-16(17(22-15)11-4-2-1-3-5-11)12-6-7-13-14(8-12)21-10-20-13;15-9-6-8(3-4-10(9)19)13-14(11-2-1-5-20-11)18-12(16)7-17-13/h1-11H,(H2,21,24);2-10H,1H3,(H2,19,23)(H,21,22);1-11,20H,(H2,19,22);1-9H,(H2,19,23)(H,21,22);1-10H,(H2,18,22)(H,20,21);1-7,19H,(H2,16,18)
InChIKeyLWTBDLSAOYVQAG-UHFFFAOYSA-N
XLogP22.69
TPSA458.89 Ų
H-Bond Donors11
H-Bond Acceptors24
Rotatable Bonds12
Heavy Atoms134
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001861.74
LogP ≤ 522.69
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1024

Analyze 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine?
The IUPAC name of 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine (CID 159478924) is 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine.
What is the SMILES notation for 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine?
The canonical SMILES for 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine is Cc1nc2ccc(-c3ncc(N)nc3-c3ccccc3)cc2[nH]1.Nc1cnc(-c2cc(Cl)c3nc[nH]c3c2)c(-c2ccccc2)n1.Nc1cnc(-c2ccc(O)c(Cl)c2)c(-c2ccco2)n1.Nc1cnc(-c2ccc3[nH]ccc3c2)c(-c2ccccc2)n1.Nc1cnc(-c2ccc3nc[nH]c3c2)c(-c2ccccc2)n1.Nc1nc(-c2ccccc2)c(-c2ccc3ncccc3c2)nc1Br.
What is the InChIKey of 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine?
The InChIKey is LWTBDLSAOYVQAG-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H13BrN4.C18H15N5.C18H14N4.C17H12ClN5.C17H13N5.C14H10ClN3O2/c20-18-19(21)24-16(12-5-2-1-3-6-12)17(23-18)14-8-9-15-13(11-14)7-4-10-22-15;1-11-21-14-8-7-13(9-15(14)22-11)17-18(23-16(19)10-20-17)12-5-3-2-4-6-12;19-16-11-21-17(18(22-16)12-4-2-1-3-5-12)14-6-7-15-13(10-14)8-9-20-15;18-12-6-11(7-13-17(12)22-9-21-13)15-16(23-14(19)8-20-15)10-4-2-1-3-5-10;18-15-9-19-16(17(22-15)11-4-2-1-3-5-11)12-6-7-13-14(8-12)21-10-20-13;15-9-6-8(3-4-10(9)19)13-14(11-2-1-5-20-11)18-12(16)7-17-13/h1-11H,(H2,21,24);2-10H,1H3,(H2,19,23)(H,21,22);1-11,20H,(H2,19,22);1-9H,(H2,19,23)(H,21,22);1-10H,(H2,18,22)(H,20,21);1-7,19H,(H2,16,18).
What are the key properties of 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine?
4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine has a molecular weight of 1861.74 g/mol, XLogP of 22.69, 12 rotatable bonds, 11 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-amino-3-(furan-2-yl)pyrazin-2-yl]-2-chlorophenol;5-(3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;3-bromo-6-phenyl-5-quinolin-6-ylpyrazin-2-amine;5-(7-chloro-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(1H-indol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methyl-3H-benzimidazol-5-yl)-6-phenylpyrazin-2-amine is sourced from PubChem (CID 159478924), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).